{"id":24231,"date":"2024-12-22T22:20:28","date_gmt":"2024-12-22T21:20:28","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&#038;p=24231"},"modified":"2026-04-19T11:35:20","modified_gmt":"2026-04-19T09:35:20","slug":"retatrutid-triple-g-pero-4-mg","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/retatrutid-triple-g-pero-4-mg\/","title":{"rendered":"Trojit\u00e9 pero G 4 mg GLP3"},"content":{"rendered":"<div data-elementor-type=\"product-post\" data-elementor-id=\"24231\" class=\"elementor elementor-24231\" data-elementor-post-type=\"product\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5c4c2fb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5c4c2fb\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fd6493e\" data-id=\"fd6493e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c7da367 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"c7da367\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 data-start=\"281\" data-end=\"362\"><strong data-start=\"284\" data-end=\"362\">Retatrutid Triple G - co je tento \u0161pi\u010dkov\u00fd peptid za\u010d?<\/strong><\/h2><p data-start=\"405\" data-end=\"888\">Retatrutid Triple G, zn\u00e1m\u00fd tak\u00e9 jako GLP 3, je inovativn\u00ed peptid nov\u00e9 generace navr\u017een\u00fd jako pokro\u010dil\u00fd agonista trojit\u00fdch inkretinov\u00fdch receptor\u016f (GLP-1, GIP a GCGR). Tato l\u00e1tka p\u0159edstavuje dal\u0161\u00ed etapu ve v\u00fdvoji metabolick\u00e9 terapie a terapie sni\u017eov\u00e1n\u00ed hmotnosti, nebo\u0165 kombinuje vlastnosti t\u0159\u00ed kl\u00ed\u010dov\u00fdch hormon\u016f zodpov\u011bdn\u00fdch za regulaci chuti k j\u00eddlu, metabolismu gluk\u00f3zy a spalov\u00e1n\u00ed energie. T\u00edm se v\u00fdrazn\u011b odli\u0161uje od d\u0159\u00edv\u011bj\u0161\u00edch p\u0159\u00edpravk\u016f, jako je semaglutid nebo tirzepatyd.<\/p><hr data-start=\"890\" data-end=\"893\" \/><h2 data-start=\"895\" data-end=\"935\"><strong data-start=\"899\" data-end=\"935\">Retatrutid Triple G - mechanismus \u00fa\u010dinku<\/strong><\/h2><p data-start=\"936\" data-end=\"1032\">Mechanismus \u00fa\u010dinku reatrutidu Triple G je zalo\u017een na sou\u010dasn\u00e9 aktivaci t\u0159\u00ed receptor\u016f:<\/p><ul><li><strong data-start=\"1035\" data-end=\"1070\">GLP-1 (glukagonu podobn\u00fd peptid-1)<\/strong> - sni\u017euje chu\u0165 k j\u00eddlu, zpomaluje vyprazd\u0148ov\u00e1n\u00ed \u017ealudku a podporuje sekreci inzul\u00ednu.<\/li><li><strong data-start=\"1157\" data-end=\"1207\">GIP (gluk\u00f3zo-dependentn\u00ed inzulinotropn\u00ed peptid)<\/strong> - zlep\u0161uje citlivost bun\u011bk na inzul\u00edn a p\u0159isp\u00edv\u00e1 k lep\u0161\u00edmu vyu\u017eit\u00ed energie.<\/li><li><strong data-start=\"1306\" data-end=\"1334\">GCGR (glukagonov\u00fd receptor)<\/strong> - zvy\u0161uje spot\u0159ebu energie a podporuje spalov\u00e1n\u00ed tuk\u016f.<\/li><\/ul><p data-start=\"1403\" data-end=\"1561\">Kombinace t\u011bchto t\u0159\u00ed mechanism\u016f vede k synergick\u00e9mu efektu - \u00fa\u010dinn\u011bj\u0161\u00ed kontrole hmotnosti, stabilizaci gluk\u00f3zy a zlep\u0161en\u00ed metabolick\u00fdch parametr\u016f.<\/p><hr data-start=\"1563\" data-end=\"1566\" \/><h2 data-start=\"1568\" data-end=\"1607\"><strong data-start=\"1572\" data-end=\"1607\">Triple G Retatrutid - \u00fa\u010dinky podle studi\u00ed (v\u011bdeck\u00e9 informace)<\/strong><\/h2><p data-start=\"1608\" data-end=\"1707\">Pou\u017eit\u00ed reatrutidu b\u011b\u017en\u011b ozna\u010dovan\u00e9ho jako GLP 3 v klinick\u00fdch studi\u00edch bylo spojeno s \u0159adou \u00fa\u010dink\u016f:<\/p><ul><li data-start=\"1710\" data-end=\"1783\">v\u00fdrazn\u00e9 sn\u00ed\u017een\u00ed t\u011blesn\u00e9 hmotnosti (v pr\u016fm\u011bru o 20-25% u <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/\">v\u00fdzkum<\/a> roku 2023),<\/li><li data-start=\"1786\" data-end=\"1831\">zlep\u0161en\u00ed kontroly hladiny cukru v krvi,<\/li><li data-start=\"1834\" data-end=\"1891\">sn\u00ed\u017een\u00ed chuti na j\u00eddlo a frekvence sva\u010dinek,<\/li><li data-start=\"1894\" data-end=\"1981\">zlep\u0161en\u00ed lipidov\u00e9ho profilu (sn\u00ed\u017een\u00ed triglycerid\u016f a LDL cholesterolu),<\/li><li data-start=\"1984\" data-end=\"2049\">zv\u00fd\u0161en\u00ed energetick\u00e9ho v\u00fddeje a zrychlen\u00ed metabolismu.<\/li><\/ul><p data-start=\"2051\" data-end=\"2262\">Retatrutid vykazuje d\u00edky sv\u00e9mu trojit\u00e9mu mechanismu v\u00fdrazn\u011b siln\u011bj\u0161\u00ed \u00fa\u010dinky ne\u017e klasick\u00e1 analoga GLP-1, co\u017e z n\u011bj \u010din\u00ed jeden z nejslibn\u011bj\u0161\u00edch peptid\u016f pro l\u00e9\u010dbu obezity a metabolick\u00e9ho syndromu.<\/p><hr data-start=\"2264\" data-end=\"2267\" \/><h2 data-start=\"2269\" data-end=\"2311\"><strong data-start=\"2273\" data-end=\"2311\">Retatrutid vs tirzepatid (v\u011bdeck\u00e9 \u00fadaje)<\/strong><\/h2><p data-start=\"2312\" data-end=\"2507\">Thiothiazepatid, kter\u00fd je du\u00e1ln\u00edm agonistou (GLP-1\/GIP), ji\u017e zp\u016fsobil revoluci v l\u00e9\u010db\u011b obezity. Retatrutid v\u0161ak p\u0159id\u00e1v\u00e1 t\u0159et\u00ed prvek - aktivaci receptor\u016f. <strong data-start=\"2467\" data-end=\"2491\">glukagon (GCGR)<\/strong>.<br data-start=\"2492\" data-end=\"2495\" \/>V\u00fdsledkem je:<\/p><ul><li data-start=\"2510\" data-end=\"2556\">Siln\u011bj\u0161\u00ed stimulace metabolismu tuk\u016f,<\/li><li data-start=\"2559\" data-end=\"2597\">v\u011bt\u0161\u00ed zv\u00fd\u0161en\u00ed energetick\u00e9ho v\u00fddeje,<\/li><li data-start=\"2600\" data-end=\"2649\">rychlej\u0161\u00ed a trvalej\u0161\u00ed v\u00fdsledky sni\u017eov\u00e1n\u00ed hmotnosti.<\/li><\/ul><p data-start=\"2651\" data-end=\"2795\">Retatrutid je zkr\u00e1tka dal\u0161\u00edm krokem po thiotrombotidu, kter\u00fd nab\u00edz\u00ed kompletn\u011bj\u0161\u00ed metabolick\u00e9 p\u016fsoben\u00ed a potenci\u00e1ln\u011b lep\u0161\u00ed klinick\u00e9 v\u00fdsledky.<\/p><p data-start=\"2651\" data-end=\"2795\">Zkontrolujte tak\u00e9 \u010dinidlo <a href=\"https:\/\/tirzepatyd.eu\/cs\/obchod-produkt\/glp-1gip-glukagon-retatrutid-8-mg-4x2mg-v-mericim-zarizeni\/\" target=\"_blank\" rel=\"noopener\">Retatrutid 8 mg v p\u0159\u00edstroji<\/a><\/p><hr data-start=\"2797\" data-end=\"2800\" \/><h2 data-start=\"2802\" data-end=\"2858\"><strong data-start=\"2806\" data-end=\"2858\">Retatrutid Triple G - d\u00e1vkovac\u00ed re\u017eimy (podle studie)<\/strong><\/h2><p data-start=\"2859\" data-end=\"3246\">V klinick\u00fdch studi\u00edch (nap\u0159. <em data-start=\"2890\" data-end=\"2930\">SURMOUNT-3 a SURPASS Obesity Extension<\/em>) pou\u017eit\u00e9 sch\u00e9ma <strong data-start=\"2950\" data-end=\"2990\">T\u00fddenn\u00ed podko\u017en\u00ed injekce<\/strong>, p\u0159i\u010dem\u017e se za\u010d\u00edn\u00e1 n\u00edzk\u00fdmi d\u00e1vkami (nap\u0159. 2 mg) a postupn\u011b se zvy\u0161uj\u00ed na 8 mg nebo 12 mg v z\u00e1vislosti na t\u011blesn\u00e9 toleranci a v\u00fdsledku l\u00e9\u010dby.<br data-start=\"3128\" data-end=\"3131\" \/>Individu\u00e1ln\u00ed d\u00e1vkov\u00e1n\u00ed by m\u011blo b\u00fdt v\u017edy stanoveno na z\u00e1klad\u011b klinick\u00fdch \u00fadaj\u016f a doporu\u010den\u00ed o\u0161et\u0159uj\u00edc\u00edho l\u00e9ka\u0159e.<\/p><hr data-start=\"3768\" data-end=\"3771\" \/><h2><strong data-start=\"3777\" data-end=\"3820\">GLP 3 - shrnut\u00ed<\/strong><\/h2><p data-start=\"3821\" data-end=\"4229\">Retatrutid GLP 3 je v sou\u010dasn\u00e9 dob\u011b ve f\u00e1zi klinick\u00fdch studi\u00ed (v\u010detn\u011b studie f\u00e1ze III spole\u010dnosti Eli Lilly) a dosud nebyl schv\u00e1len pro \u0161irok\u00fd marketing. Dosavadn\u00ed v\u00fdsledky v\u011bdeck\u00fdch anal\u00fdz v\u0161ak nazna\u010duj\u00ed, \u017ee m\u016f\u017ee p\u0159edstavovat nej\u00fa\u010dinn\u011bj\u0161\u00ed formu metabolick\u00e9 l\u00e9\u010dby nov\u00e9 generace.<br data-start=\"4107\" data-end=\"4110\" \/>Tento peptid m\u016f\u017ee v p\u0159\u00ed\u0161t\u00edch letech zp\u016fsobit revoluci v l\u00e9\u010db\u011b obezity a poruch hospoda\u0159en\u00ed s cukrem.<\/p><p data-start=\"3821\" data-end=\"4229\"><a href=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-25348 size-medium\" src=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-300x192.png\" alt=\"Retatrutidov\u00fd peptid Triple G GLP 3 4 mg v odm\u011b\u0159ovac\u00edm za\u0159\u00edzen\u00ed (pero) pro v\u00fdzkumn\u00e9 pou\u017eit\u00ed\" width=\"300\" height=\"192\" srcset=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-300x192.png 300w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-400x256.png 400w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-800x513.png 800w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-64x41.png 64w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-1024x656.png 1024w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-768x492.png 768w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-1536x985.png 1536w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259.png 1663w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p><hr data-start=\"3768\" data-end=\"3771\" \/><p><strong>Zdroj:<\/strong><br \/><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2301972\">Agonista trojit\u00e9ho hormon\u00e1ln\u00edho receptoru retatrutid pro l\u00e9\u010dbu obezity - studie f\u00e1ze 2<\/a><\/p><div class=\"elementor-element elementor-element-6cde8ce elementor-widget elementor-widget-text-editor\" data-id=\"6cde8ce\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\"><div class=\"elementor-widget-container\"><p><strong>V\u00fdrobek je ur\u010den pro v\u011bdeck\u00fd v\u00fdzkum a laboratorn\u00ed anal\u00fdzy. V\u0161echny \u010dl\u00e1nky a informace na t\u011bchto webov\u00fdch str\u00e1nk\u00e1ch slou\u017e\u00ed pouze k informa\u010dn\u00edm a vzd\u011bl\u00e1vac\u00edm \u00fa\u010del\u016fm.<\/strong><\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Retatrutid Pen (GLP-3) je v centru pozornosti sou\u010dasn\u00e9ho v\u00fdzkumu metabolick\u00fdch peptid\u016f, kter\u00fd se zam\u011b\u0159uje na regulaci chuti k j\u00eddlu, hospoda\u0159en\u00ed s energi\u00ed a rovnov\u00e1hu t\u011blesn\u00e9 hmotnosti. Certifikovan\u00fd v\u00fdrobek s p\u0159ilo\u017een\u00fdm certifik\u00e1tem o anal\u00fdze (CoA).<\/p>","protected":false},"featured_media":25348,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[122,109,15],"product_tag":[],"class_list":{"0":"post-24231","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-penie","7":"product_cat-triple-g","8":"product_cat-laboratory-research","10":"first","11":"instock","12":"sale","13":"shipping-taxable","14":"purchasable","15":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/24231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/comments?post=24231"}],"version-history":[{"count":24,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/24231\/revisions"}],"predecessor-version":[{"id":35481,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product\/24231\/revisions\/35481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media\/25348"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/media?parent=24231"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_brand?post=24231"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_cat?post=24231"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/cs\/wp-json\/wp\/v2\/product_tag?post=24231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}